Model
Edge
Revance Therapeutics Inc.
0001532023
Filing Type
4
Filing Date
2/5/2025
Updated
2/6/25, 6:06 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership